The CIMBA retrospective cohort consisted of 18,935 BRCA1 carriers (9473 diagnosed with breast and 2068 with ovarian cancer) and 12,339 BRCA2 carriers (6332 with breast and 718 with ovarian cancer, Table S3). This evidence concerns the gene BRCA2 and ovarian cancer.